REM-001
Phase 3- Indications
- Cutaneous metastatic breast cancer, Biliary cancer, Basal cell carcinoma
Company intelligence / Profile preview
Edgemont Pharmaceuticals
Austin, Texas, United Statesprnewswire.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
Edgemont Pharmaceuticals was a privately held specialty pharmaceutical company focused on psychiatry and neuroscience. It commercialized two FDA-approved antidepressant products in the US—Forfivo XL and Fluoxetine Tablets—and had a Phase III product candidate for generalized anxiety disorder. The company also licensed CPI‑300, a high-dose bupropion HCl formulation, from IntelGenx for US commercialization. As of the latest available information, Edgemont appears to be inactive or defunct.
- Therapeutic areas
- PsychiatryCardiovascular
- Modalities
- Small moleculesNovel drug formulations
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
IntelGenx Corp. (license agreement for CPI‑300/Forfivo XL commercialization in US)
Beyond the preview
Go deeper on Edgemont Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Edgemont Pharmaceuticals.